What's not mentioned by Pisano about biotechnology?
A.
By 2006 a great deal of money had been invested in developing biotechnology with a belief that it could transform healthcare in the US
B.
An industry model that had been used successfully with computer and software companies was quite applicable to a biotechnological context.
C.
There was a conflict between, on the one hand, how industry manages and rewards risks and how businesses are funded, and on the other hand, the research and development timetable required to create new drugs.
D.
The period taken to confirm the safety and effectiveness of a newly developed drug is lengthy, involving a process of trial and error.